165 related articles for article (PubMed ID: 33278800)
21. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor function in motor neuron survival and degeneration.
Cary GA; La Spada AR
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):479-94, viii. PubMed ID: 18625411
[TBL] [Abstract][Full Text] [Related]
23. The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis.
Pasquali L; Ruffoli R; Fulceri F; Pietracupa S; Siciliano G; Paparelli A; Fornai F
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):268-78. PubMed ID: 20406184
[TBL] [Abstract][Full Text] [Related]
24. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
25. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia.
Shiao YM; Lee CC; Hsu YH; Huang SF; Lin CY; Li LH; Fann CS; Tsai CY; Tsai SF; Chiu HC
J Neuroimmunol; 2010 Apr; 221(1-2):101-6. PubMed ID: 20223524
[TBL] [Abstract][Full Text] [Related]
26. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
27. CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice.
Liu S; Liu X; Xiong H; Wang W; Liu Y; Yin L; Tu C; Wang H; Xiang X; Xu J; Duan B; Tao A; Zhao Z; Mei Z
Brain Behav Immun; 2019 Aug; 80():711-724. PubMed ID: 31100371
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection in amyotrophic lateral sclerosis: from pathology to treatment.
Murri L
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):258. PubMed ID: 20406186
[No Abstract] [Full Text] [Related]
29. The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord.
Genc B; Gozutok O; Kocak N; Ozdinler PH
Cells; 2020 Feb; 9(2):. PubMed ID: 32098365
[TBL] [Abstract][Full Text] [Related]
30. CXCL13/CXCR5 signaling axis in cancer.
Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of CXCR5 and CXCL13 in mice with experimental autoimmune myocarditis.
Han FL; Liang F; Jiang TC; Liu M
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1860-1867. PubMed ID: 28485792
[TBL] [Abstract][Full Text] [Related]
32. Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease.
Bigini P; Steffensen KR; Ferrario A; Diomede L; Ferrara G; Barbera S; Salzano S; Fumagalli E; Ghezzi P; Mennini T; Gustafsson JA
J Neuropathol Exp Neurol; 2010 Jun; 69(6):593-605. PubMed ID: 20467332
[TBL] [Abstract][Full Text] [Related]
33. Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage.
Ticozzi N; Ratti A; Silani V
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):285-96. PubMed ID: 20406182
[TBL] [Abstract][Full Text] [Related]
34. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.
Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L
J Neuropathol Exp Neurol; 2005 Jul; 64(7):605-12. PubMed ID: 16042312
[TBL] [Abstract][Full Text] [Related]
35. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
Yang C; Danielson EW; Qiao T; Metterville J; Brown RH; Landers JE; Xu Z
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6209-E6218. PubMed ID: 27681617
[TBL] [Abstract][Full Text] [Related]
36. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
37. The roles of chemokine (C-X-C motif) ligand 13 in spinal cord ischemia-reperfusion injury in rats.
Chen F; Li X; Li Z; Zhou Y; Qiang Z; Ma H
Brain Res; 2020 Jan; 1727():146489. PubMed ID: 31589828
[TBL] [Abstract][Full Text] [Related]
38. CXCR5-CXCL13 axis markers in full-term and preterm human neonates in the first weeks of life.
Pietrasanta C; De Leo P; Jofra T; Ronchi A; Pugni L; Mosca F; Aiuti A; Cicalese MP; Fousteri G
Eur J Immunol; 2021 May; 51(5):1289-1292. PubMed ID: 33491181
[TBL] [Abstract][Full Text] [Related]
39. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
40. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]